Estrella Immunopharma Inc. (ESLA)
Healthcare
Biotechnology
0.71 $
-0.9%
vs. previous close
Closing price · As of: 31. Jul 2026
Estrella Immunopharma Inc. (ESLA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -1.8 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| -0.7 | -1.4 | -1.0 | -16 | -7.6 | -1.8 | |
| 0.1 | 0.1 | 0.3 | 1.2 | 1.2 | 0.6 | |
| 0.1 | 0.1 | 0.4 | – | – | – | |
| 0.0 | 0.1 | 0.6 | -10.0 | 0.8 | 11 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -0.3 | -45 | 36 | – | 5.0 | – | |
| – | 0.0 | -36 | -0.4 | -0.6 | 0.0 | |
| – | – | 0.0 | 0.0 | – | – | |
| 0.7 | 5.5 | -36 | 13 | -0.5 | 2.3 | |
| 4.1 | 4.1 | -0.4 | 1.7 | -8.1 | 0.5 | |
| -0.7 | -1.4 | -1.0 | -16 | -7.6 | -1.8 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.